Atlas Trials

Single Ascending Oral Dose Study to Investigate the Effects of OCT461201 in Healthy Volunteers

Clinical trial NCT06398925 · COMPLETED

Trial details

NCT number
NCT06398925
Sponsor
Oxford Cannabinoid Technologies Holdings PLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2023-07-26
Primary completion
2023-09-25
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.